News - Page 227 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Red Light Holland Looking To Receive Exemption for Controlled Substances from Government of Canada, Engages Wellington Dupont Public Affairs

Red Light Holland Looking To Receive Exemption for Controlled Substances from Government of Canada, Engages Wellington Dupont Public Affairs

Post published:December 23, 2020
Post category:Press Release

Read more about the article BetterLife Welcomes Psychedelic Industry Leaders to the Senior Management Team

BetterLife Welcomes Psychedelic Industry Leaders to the Senior Management Team

Post published:December 23, 2020
Post category:Press Release

Read more about the article Psyched Wellness Commences Pre-Clinical Trials of Amanita Muscaria

Psyched Wellness Commences Pre-Clinical Trials of Amanita Muscaria

Post published:December 23, 2020
Post category:Press Release

Read more about the article Havn Life Sciences and Nesters Market, a Leading Canadian Retailer of Natural Health and Wellness Products, Announce an Authorized Products Listing

Havn Life Sciences and Nesters Market, a Leading Canadian Retailer of Natural Health and Wellness Products, Announce an Authorized Products Listing

Post published:December 22, 2020
Post category:Press Release

Read more about the article Mindset Pharma to Commence Trading on the CSE on December 23, 2020 Under the Symbol “MSET”

Mindset Pharma to Commence Trading on the CSE on December 23, 2020 Under the Symbol “MSET”

Post published:December 22, 2020
Post category:Press Release

Read more about the article Novamind Receives CSE Conditional Listing Approval Under the Ticker “NM”

Novamind Receives CSE Conditional Listing Approval Under the Ticker “NM”

Post published:December 22, 2020
Post category:Press Release

Read more about the article MagicMed Industries Announces the Establishment of Psilocybin-Derivatives Portfolio and Launch of Candidate Selection Program

MagicMed Industries Announces the Establishment of Psilocybin-Derivatives Portfolio and Launch of Candidate Selection Program

Post published:December 22, 2020
Post category:Press Release

Read more about the article Tryp Therapeutics Appoints Peter Guzzo, PhD, as Vice President, Drug Development

Tryp Therapeutics Appoints Peter Guzzo, PhD, as Vice President, Drug Development

Post published:December 22, 2020
Post category:Press Release

Read more about the article MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing

MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing

Post published:December 21, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials

Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials

Post published:December 21, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.